跳至主要内容
临床试验/EUCTR2008-004807-67-GR
EUCTR2008-004807-67-GR进行中(未招募)不适用

AN OPEN-LABEL, NON-RANDOMIZED PHASE IV CLINICAL TRIAL OF THE EFFICACY OF INTRAVENOUSLY ADMINISTERED 1000MG PARACETAMOL AS ANTIPYRETIC AND ANALGESIC MEDICATION - ?NTRAVENOUS 1000MG PARACETAMOL AS ANTIPYRETIC AND ANALGESIC MEDICATIO

niversity of Athens, Medical School0 个研究点开始时间: 2009年2月18日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age greater than or equal to 18 years
  • Written informed consent by the patients
  • Medical condition necessitating the administration of antipyretic or analgesic medications
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • ?ge lower than 18 years
  • Lack of informed consent
  • History of liver cirrhosis
  • Blood creatinine greater than 3mg/dl
  • Blood AST greater than 3 times the upper normal level according to the lab of the participating hospital
  • History of hypersensitivity to non-steroidal ant-iinflammatory drugs
  • History of abuse of analgesics
  • Pregnancy or lactation
  • Fulminant hemorrhage of the upper or lower digestive tract
  • Thrombocytopenia defined as less than 50000 platelets/µl

研究者

发起方
niversity of Athens, Medical School

相似试验

AN OPEN-LABEL, NON-RANDOMIZED PHASE IV CLINICAL... | 临床试验